☆ 4.6 Article

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples

VIRUSES-BASEL (2021)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review

Chanyan Huang et al.

Summary: This study synthesized clinical characteristics, treatment, and outcomes among critically ill patients with COVID-19, revealing common characteristics such as older male patients with comorbidities and severe illness. Differences in regions included newly identified complications and different rates of mechanical ventilation use.

MAYO CLINIC PROCEEDINGS (2021)

Add to Collection

Article Hematology

Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing

Alfredo Mendrone-Junior et al.

Summary: This study suggests that SARS-CoV-2 IgG immunoassays (S/CO) can predict high anti-SARS-CoV-2 nAbs titers. Different criteria for identifying donors with >= 1:160 nAbs titers have been proposed in this study, all showing high efficacy.

TRANSFUSION (2021)

Add to Collection

Article Hematology

Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

Heli Harvala et al.

Summary: The study evaluated the relationship between neutralising antibody titres and ELISA test results, finding that EUROimmun immunoglobulin G (IgG) had the best correlation with neutralising antibody titres and potential utility for scaled-up production of therapeutic levels of anti-SARS-CoV-2 neutralising antibodies.

TRANSFUSION MEDICINE (2021)

Add to Collection

Review Immunology

SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic Response

Adi Gundlapalli et al.

Summary: There is a current lack of standardized SARS-CoV-2 quantitative IgG and neutralization assays, which hinders the comparison of results from different studies. Most studies have used in-house laboratory-developed tests with non-standardized reporting methods. It is vital to enhance interassay and interlaboratory validation and standardization in order to better understand immune responses and vaccine efficacy.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Comparison of Four SARS-CoV-2 Neutralization Assays

Lydia Riepler et al.

Summary: Neutralizing antibodies are crucial for protection against viruses like SARS-CoV-2. This study compared four different assays for detecting these antibodies and found that they were all robust and yielded comparable results, indicating their reliability.

VACCINES (2021)

Add to Collection

Review Virology

Understanding of COVID-19 based on current evidence

Pengfei Sun et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Biochemical Research Methods

SciPy 1.0: fundamental algorithms for scientific computing in Python

Pauli Virtanen et al.

NATURE METHODS (2020)

Add to Collection

Correction Biochemical Research Methods

SciPy 1.0: fundamental algorithms for scientific computing in Python (vol 33, pg 219, 2020)

Pauli Virtanen et al.

NATURE METHODS (2020)

Add to Collection

Article Microbiology

An Infectious cDNA Clone of SARS-CoV-2

Xuping Xie et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Virology

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays

Lisa Weidner et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Immunology

Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting

Katherine Bond et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Microbiology

Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2

Sandra C. A. Nielsen et al.

CELL HOST & MICROBE (2020)

Add to Collection

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard et al.

SCIENCE (2020)

Add to Collection

Review Immunology

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Yannick Galipeau et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Immunology

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Baoqing Sun et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples

Elena N. Postnikova et al.

PLOS ONE (2019)

Add to Collection

Article Cell Biology

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

Thomas Luke et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.